Skip to content

H.R. 4215 · 118th Congress (2023–2025)

End Price Gouging for Medications Act

This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries.

Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.

Show official title

To require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 4215’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Debbie Dingell (D-MI-6)
Policy area
Health
Subjects
  • Asia
  • Australia
  • Canada
  • Civil actions and liability
  • Europe
  • France
  • Germany
  • Health care costs and insurance
  • 18 more
    • Health care coverage and access
    • Inflation and prices
    • Italy
    • Japan
    • Medicaid
    • Medical research
    • Medicare
    • Military medicine
    • Netherlands
    • North America
    • Oceania
    • Prescription drugs
    • Retail and wholesale trades
    • Spain
    • Sweden
    • Switzerland
    • United Kingdom
    • Veterans' medical care

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 4 committee actions · Jun 20, 2023 – Dec 17, 2024
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Accountability, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    4. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseArmed ServicesReferred Jun 20, 2023
  2. HouseOversight and AccountabilityReferred Jun 20, 2023
  3. HouseEnergy and CommerceReferred Jun 20, 2023
  4. HouseHealthReferred Jun 23, 2023
  5. HouseNatural ResourcesReferred Jun 20, 2023
  6. HouseVeterans' AffairsReferred Jun 20, 2023
  7. HouseHealthReferred Jul 19, 2023
  8. HouseWays and MeansReferred Jun 20, 2023
  9. HouseHealthReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. End Price Gouging for Medications Act

    Display title, Short title · Introduced in House

  2. To require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.

    Official title · Introduced in House